Nemifitide ditriflutate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNemifitide ditriflutate
Drug Alias NameNetamiftide trifluoroacetateINN-00835
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin transporter inhibitors
TargetsSerotonin 2a (5-HT2a) receptorSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTetragenex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTetragenex
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG